Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20210717002Phase 4Completed
Phase 4, open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by National Research Council of Thailand. Primary endpoints: Safety outcomes and Immunological responses. Started Aug 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20210717002.